Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEVERWOUND: Early vs Delayed Everolimus in Kidney Transplant
NCT01410448Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in kidney transplant rejection, sponsored by Novartis. Started Nov 2011; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01410448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410448.